All Anne-Marie Rick articles

  • Human_Respiratory_Syncytial_Virus_(RSV)_-_52456179236
    News

    Maternal RSV vaccine cuts infant hospitalizations by 70%

    2026-06-08T09:29:00Z

    A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants.